For research use only. Not for therapeutic Use.
IEM-1460 blocks both AMPA and NMDA glutamate receptor with anticonvulsant effect in vivo[1].
Catalog Number | I010436 |
CAS Number | 121034-89-7 |
Synonyms | 5-(1-adamantylmethylamino)pentyl-trimethylazanium;bromide;hydrobromide |
Molecular Formula | C19H38Br2N2 |
Purity | ≥95% |
InChI | InChI=1S/C19H37N2.2BrH/c1-21(2,3)8-6-4-5-7-20-15-19-12-16-9-17(13-19)11-18(10-16)14-19;;/h16-18,20H,4-15H2,1-3H3;2*1H/q+1;;/p-1 |
InChIKey | CQTDZUSQSTUZDA-UHFFFAOYSA-M |
SMILES | C[N+](C)(C)CCCCCNCC12CC3CC(C1)CC(C3)C2.Br.[Br-] |
Reference | [1]. Schlesinger F, et al. Two mechanisms of action of the adamantane derivative IEM-1460 at human AMPA-type glutamate receptors. Br J Pharmacol. 2005 Jul;145(5):656-63. |